MedPage Today on MSN10d
Have the New Pulmonary Hypertension Drugs Changed the Game?
After the FDA approved both combination macitentan/tadalafil (Opsynvi) and the biologic therapy sotatercept (Winrevair) for ...
Medscape11d
A Case Series of Five Infants with Scimitar Syndrome
It may be difficult to determine which of these many factors are responsible for the pulmonary hypertension in an individual patient, so each factor should be considered and investigated.
pulmonologyadvisor9d
Study Shows Sotatercept Efficacious and Safe in Pulmonary Arterial Hypertension
Increasing average concentrations of sotatercept improved 6-minute walk distance, pulmonary vascular resistance, and levels ...
openaccessgovernment5d
Sotatercept approved for pulmonary arterial hypertension
A new treatment, Sotatercept, for pulmonary arterial hypertension (PAH) has recently been approved by the MHRA ...
Hosted on MSN6d
UK MHRA approves MSD’s pulmonary arterial hypertension therapy
MSD has received the UK Medicines and Healthcare products Regulatory Agency (MHRA) approval for sotatercept, marketed as ...